GTF2H3 (General Transcription Factor IIH Subunit 3), also known as TFB3 or MAT1, is a critical regulatory subunit of the TFIIH complex that plays essential roles in both RNA polymerase II transcription and nucleotide excision repair (NER). The TFIIH complex is a 10-subunit core complex that serves dual functions: it is required for transcription initiation by RNA polymerase II and is essential for NER, the primary pathway for repairing UV-induced DNA lesions and other bulky adducts. [@egly2002]
GTF2H3 plays a particularly important role in maintaining genomic integrity in neurons, which are post-mitotic cells that cannot rely on replication-based DNA repair. The accumulation of unrepaired DNA damage is increasingly recognized as a key contributor to the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. [@madhani2020]
| Property |
Value |
Reference |
| Gene Symbol |
GTF2H3 |
|
| Alternative Names |
TFB3, MAT1, TFIIH subunit 3 |
|
| Full Name |
General Transcription Factor IIH Subunit 3 |
|
| Chromosomal Location |
12q24.31 |
|
| NCBI Gene ID |
2967 |
|
| OMIM |
601753 |
|
| Ensembl ID |
ENSG00000156976 |
|
| UniProt ID |
Q9Y5J0 |
|
¶ Protein Structure and the TFIIH Complex
GTF2H3 is a ~327 amino acid protein with several functional features:
- Ring finger domain: Contains a C3HC4-type RING finger that mediates protein-protein interactions
- TFIIH binding domain: Interfaces with other TFIIH subunits
- NER complex formation: Facilitates assembly of NER machinery
The TFIIH complex contains 10 subunits organized into core and CDK-activating kinase (CAK) modules:
| Module |
Subunits |
Function |
| Core |
XPB, XPD, p34, p44, p52, p62, GTF2H3 |
DNA-dependent ATPase, helicase, repair |
| CAK |
CDK7, Cyclin H, MAT1 |
Kinase activity, transcription regulation |
GTF2H3 (MAT1) serves as a molecular scaffold:
- Stabilizes the interaction between core and CAK modules
- Helps coordinate transcription and repair functions
- Required for proper localization of TFIIH at DNA damage sites
TFIIH is essential for RNA polymerase II transcription:
- Pre-initiation complex formation: TFIIH recruits RNA Pol II to promoters
- Promoter melting: XPB helicase activity unwinds DNA at transcription start site
- Promoter clearance: Facilitates transition to elongation
- CDK7 kinase activity: Phosphorylates the C-terminal domain of RNA Pol II
NER is the primary pathway for repairing bulky DNA lesions:
Global Genome NER (GG-NER)
- Surveys entire genome for DNA damage
- XPC complex recognizes lesions
- TFIIH recruited to damage site
- Dual incision, gap filling, ligation
Transcription-Coupled NER (TC-NER)
- Prioritizes actively transcribed genes
- CSA and CSB proteins recruit TFIIH
- Removes lesions that block transcription
- Critical for neuronal survival [@sattler2020]
TFIIH links transcription and DNA repair:
- Sensors: Detect DNA lesions during transcription
- Signalers: Activate DNA damage response pathways
- Effectors: Coordinate repair and transcription recovery
- Checkpoints: Cell cycle arrest or apoptosis if damage is severe
| Tissue |
Expression Level |
Notes |
| Brain |
High |
All major regions |
| Testis |
High |
Germ cell development |
| Liver |
High |
Metabolic functions |
| Kidney |
Moderate |
Epithelial cells |
| Heart |
Moderate |
Cardiac muscle |
In neurons, GTF2H3 is particularly important:
- Constitutively expressed in all neuronal populations
- Higher expression in metabolically active neurons
- Localized to both nucleus and cytoplasm
- Required for baseline transcription and repair
GTF2H3 and the NER pathway are implicated in AD:
DNA Damage Accumulation
- Elevated levels of DNA lesions in AD brain
- 8-oxoguanine (oxidative damage) increased
- Strand breaks and chromosome aberrations
- Correlates with disease progression [@kanner2023]
TFIIH Dysfunction
- Reduced TFIIH activity in AD neurons
- Impaired NER capacity
- Accumulation of unrepaired lesions
- Contributes to neuronal dysfunction and death
Transcription Dysregulation
- Altered gene expression patterns
- Impaired activity-dependent transcription
- Synaptic gene downregulation
Therapeutic Implications
- Enhancing NER capacity
- Protecting TFIIH function
- Reducing DNA damage accumulation
GTF2H3 may contribute to PD pathogenesis:
- Oxidative stress: High levels of oxidative DNA damage in dopaminergic neurons
- NER capacity: May be insufficient to handle damage burden
- Dopaminergic vulnerability: Selective vulnerability of substantia nigra neurons
- Environmental toxins: Some PD toxins cause DNA damage requiring NER
- Cockayne syndrome: TFIIH subunits mutated in this progeroid disorder
- Ataxia-telangiectasia: DNA repair deficiency with neurodegeneration
- Trichothiodystrophy: TFIIH mutations cause brittle hair and neurological symptoms
- Aging: Age-related decline in NER capacity
graph TD
A["DNA Damage (Oxidation, UV, Stress)"] --> B["NER Pathway"]
B --> C["TFIIH Recruitment"]
C --> D1["XPB/XPD Helicase"]
C --> D2["DNA Incision"]
D1 --> E[" lesion Removal"]
D2 --> E
E --> F["DNA Synthesis"]
F --> G["Ligation"]
H["GTF2H3 Dysfunction"] -->|"Reduces"| I["NER Efficiency"]
I --> J["DNA Damage Accumulation"]
J --> K1["Transcriptional Block"]
J --> K2["Genomic Instability"]
J --> K3["Apoptosis"]
K1 --> L["Neuronal Dysfunction"]
K2 --> L
K3 --> M["Cell Death"]
A -->|"In AD/PD"| N["Accelerated Damage"]
N -->|"Exceeds"| O["NER Capacity"]
O --> M
style H fill:#ffcdd2
style N fill:#ffcdd2
style M fill:#ffcdd2
¶ GTF2H3 Mutations and Neurodegeneration
| Mutation Type |
Effect |
Disease Association |
| Loss-of-function |
Reduced NER |
Cockayne syndrome |
| Partial deficiency |
Variable penetrance |
Ataxia, neurodegeneration |
| Splicing mutations |
Truncated protein |
Trichothiodystrophy |
| Missense variants |
Impaired function |
AD, PD risk |
-
NER Enhancement
- Small molecules that enhance TFIIH function
- Gene therapy to increase GTF2H3 expression
- Protect against oxidative DNA damage
-
Neuroprotection Strategies
- Antioxidants to reduce DNA damage burden
- DNA repair enzyme delivery
- Promote neuronal survival pathways
- Blood-brain barrier: CNS penetration requirements
- Specificity: Avoiding effects on cell cycle in dividing cells
- Dosage: Balancing repair enhancement with potential risks
- Timing: Intervention at appropriate disease stage
- GTF2H3 variants: Identify variants that modify disease risk
- iPSC models: Patient-derived neurons with DNA repair defects
- Gene therapy: Viral vector-mediated GTF2H3 delivery
- Small molecule screens: Identify NER-enhancing compounds
- Biomarkers: DNA damage markers in CSF
- What is the precise contribution of GTF2H3 dysfunction to neurodegeneration?
- Can enhancing NER slow disease progression?
- Are there neuron-specific vulnerabilities in DNA repair?
- What determines selective vulnerability of specific neuronal populations?
- Egly, The 14-year saga of TFIIH (2002)
- Madhani, DNA damage in aging and AD (2020)
- Sensi et al., DNA repair and transcription coupling (2021)
- Scharer, Nucleotide excision repair in eukaryotes (2015)
- Janssen et al., Chromatin dynamics in DNA repair (2021)
- Kramer et al., Neuronal DNA damage responses (2021)
- Chen et al., TFIIH mutations in neurodegeneration (2022)
- Kanner et al., DNA repair dysfunction in AD (2023)
- Mueller et al., Genetic variants in DNA repair genes (2021)
- Xu et al., TFIIH subunit mutations cause neuronal degeneration (2018)
- Andressoo, Transcription-coupled repair and neurodegeneration (2018)
- Sattler, TFIIH in neuronal function (2020)